Michela Nose

Summary

Affiliation: University of Verona
Country: Italy

Publications

  1. ncbi [Systemic review of clinical interventions for reducing treatment non-adherence in psychosis]
    Michela Nose
    Dipartimento di Medicina e Sanita Pubblica, Sezione di Psichiatria, Universita di Verona, Policlinico G B Rossi, P le L A Scuro 10, 37134 Verona
    Epidemiol Psichiatr Soc 12:272-86. 2003
  2. ncbi Adverse effects of antipsychotic drugs: survey of doctors' versus patients' perspective
    Michela Nose
    Department of Public Health and Community Medicine, Section of Psychiatry and Clinical Psychology, University of Verona, Policlinico GB Rossi, 37134 Verona, Italy
    Soc Psychiatry Psychiatr Epidemiol 47:157-64. 2012
  3. ncbi Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment-resistant schizophrenia
    Michela Nose
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Italy
    Trials 10:31. 2009
  4. ncbi Is the Defined Daily Dose system a reliable tool for standardizing antipsychotic dosages?
    Michela Nose
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Italy
    Int Clin Psychopharmacol 23:287-90. 2008
  5. ncbi Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence
    Corrado Barbui
    Section of Psychiatry and Clinical Psychology, Department of Medicine and Public Health, University of Verona, Verona, Italy
    Psychopathology 42:311-7. 2009
  6. ncbi Persistence with polypharmacy and excessive dosing in patients with schizophrenia treated in four European countries
    Corrado Barbui
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Verona, Italy
    Int Clin Psychopharmacol 21:355-62. 2006
  7. ncbi Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial
    Corrado Barbui
    World Health Organization Collaborating Centre for Research and Training in Mental Health and Service Organization, Department of Public Health and Community Medicine, Section of Psychiatry and Clinical Psychology, Verona, Italy
    J Clin Psychopharmacol 31:266-73. 2011
  8. ncbi Determinants of first- and second-generation antipsychotic drug use in clinically unstable patients with schizophrenia treated in four European countries
    Corrado Barbui
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Italy
    Int Clin Psychopharmacol 21:73-9. 2006
  9. ncbi Understanding antipsychotic non-classical prescriptions: a quantitative and qualitative approach
    Antonio Veronese
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Piazzale L A Scuro 10, 37134 Verona, Italy
    Epidemiol Psichiatr Soc 17:236-41. 2008
  10. ncbi Development of a registry for monitoring psychotropic drug prescriptions: aims, methods and implications for ordinary practice and research
    Corrado Barbui
    Department of Medicine and Public Health, Section of Psychiatry, University of Verona, Italy
    Int J Methods Psychiatr Res 14:151-7. 2005

Detail Information

Publications19

  1. ncbi [Systemic review of clinical interventions for reducing treatment non-adherence in psychosis]
    Michela Nose
    Dipartimento di Medicina e Sanita Pubblica, Sezione di Psichiatria, Universita di Verona, Policlinico G B Rossi, P le L A Scuro 10, 37134 Verona
    Epidemiol Psichiatr Soc 12:272-86. 2003
    ..This systematic review was carried out to investigate the efficacy of clinical interventions that community psychiatric services can implement to reduce non-adherence in patients with psychosis...
  2. ncbi Adverse effects of antipsychotic drugs: survey of doctors' versus patients' perspective
    Michela Nose
    Department of Public Health and Community Medicine, Section of Psychiatry and Clinical Psychology, University of Verona, Policlinico GB Rossi, 37134 Verona, Italy
    Soc Psychiatry Psychiatr Epidemiol 47:157-64. 2012
    ..The aim of this survey is to compare doctors' versus patients' perspective on the presence and level of distress due to antipsychotic adverse effects in a sample of patients under the care of the South-Verona mental health services...
  3. ncbi Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment-resistant schizophrenia
    Michela Nose
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Italy
    Trials 10:31. 2009
    ....
  4. ncbi Is the Defined Daily Dose system a reliable tool for standardizing antipsychotic dosages?
    Michela Nose
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Italy
    Int Clin Psychopharmacol 23:287-90. 2008
    ..In conclusion, this study found that the DDD system is a reliable tool for standardizing antipsychotic doses in drug utilization research...
  5. ncbi Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence
    Corrado Barbui
    Section of Psychiatry and Clinical Psychology, Department of Medicine and Public Health, University of Verona, Verona, Italy
    Psychopathology 42:311-7. 2009
    ..Factors influencing patient and clinician perspectives in the assessment of medication adherence have never been compared...
  6. ncbi Persistence with polypharmacy and excessive dosing in patients with schizophrenia treated in four European countries
    Corrado Barbui
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Verona, Italy
    Int Clin Psychopharmacol 21:355-62. 2006
    ..Clinicians should consider that dose reduction strategies have been shown to be a feasible intervention in patients with schizophrenia...
  7. ncbi Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial
    Corrado Barbui
    World Health Organization Collaborating Centre for Research and Training in Mental Health and Service Organization, Department of Public Health and Community Medicine, Section of Psychiatry and Clinical Psychology, Verona, Italy
    J Clin Psychopharmacol 31:266-73. 2011
    ..However, an advantage in the perception of adverse effects with aripiprazole treatment may be meaningful for patients...
  8. ncbi Determinants of first- and second-generation antipsychotic drug use in clinically unstable patients with schizophrenia treated in four European countries
    Corrado Barbui
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Italy
    Int Clin Psychopharmacol 21:73-9. 2006
    ..Physicians tended to reserve polypharmacy for difficult-to-treat patients (i.e. for managing situations where, despite the lack of an evidence base, there is a pressing need to provide clinical answers)...
  9. ncbi Understanding antipsychotic non-classical prescriptions: a quantitative and qualitative approach
    Antonio Veronese
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Piazzale L A Scuro 10, 37134 Verona, Italy
    Epidemiol Psichiatr Soc 17:236-41. 2008
    ..The present study was carried out to develop concepts which help understand this phenomenon in a natural setting, giving emphasis to views of clinicians according to quali - quantitative research methodologies...
  10. ncbi Development of a registry for monitoring psychotropic drug prescriptions: aims, methods and implications for ordinary practice and research
    Corrado Barbui
    Department of Medicine and Public Health, Section of Psychiatry, University of Verona, Italy
    Int J Methods Psychiatr Res 14:151-7. 2005
    ....
  11. ncbi Sex differences in the subjective tolerability of antipsychotic drugs
    Corrado Barbui
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Italy
    J Clin Psychopharmacol 25:521-6. 2005
    ..Studies should no longer consider men and women as a homogeneous group, given that the subjective tolerability of antipsychotic drugs substantially differs between sexes...
  12. ncbi Changes and predictors of change in objective and subjective quality of life: multiwave follow-up study in community psychiatric practice
    Mirella Ruggeri
    Dipartimento di Medicina e Sanita Pubblica, Sezione di Psichiatria e di Psicologia Clinica, Universita di Verona, Policlinico G B Rossi, 37134 Verona, Italy
    Br J Psychiatry 187:121-30. 2005
    ..There is little knowledge of the predictors of objective and subjective quality of life...
  13. ncbi Antidepressant drug prescription and risk of abnormal bleeding: a case-control study
    Corrado Barbui
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, WHO Collaborating Centre for Research and Training in Mental Health, University of Verona, Italy
    J Clin Psychopharmacol 29:33-8. 2009
    ..74; 95% CI, 1.04-2.93). In a population with a low baseline risk of bleeding, we detected a significant increase in the risk of gastrointestinal bleeding only...
  14. ncbi Drug treatment modalities in psychiatric inpatient practice: a 20-year comparison
    Corrado Barbui
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Ospedale Policlinico, 37134 Verona, Italy
    Eur Arch Psychiatry Clin Neurosci 255:136-42. 2005
    ....
  15. ncbi What is a risk ratio?
    Andrea Cipriani
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Piazzale L.A. Scuro, 10, 37134 Verona, Italy
    Epidemiol Psichiatr Soc 16:20-1. 2007
  16. ncbi Allocation concealment and blinding in clinical trials
    Andrea Cipriani
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Verona, Italy
    Epidemiol Psichiatr Soc 17:115-6. 2008
  17. ncbi Cerebral atrophy and white matter disruption in chronic schizophrenia
    Nicola Andreone
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Verona, Italy
    Eur Arch Psychiatry Clin Neurosci 257:3-11. 2007
    ..It also suggested that physiological aging effects on brain anatomy may be abnormally pronounced in schizophrenia...
  18. ncbi Generating psychotropic drug exposure data from computer-based medical records
    Chiara Bonetto
    Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Verona, Italy
    Comput Methods Programs Biomed 83:120-4. 2006
    ....